Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan 1;203(1):145-148.
doi: 10.1164/rccm.202008-3157LE.

Reply to Wang and Lai: The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease

MeiLan K Han  1 , David A Lipson  2   3 , Dave Singh  4 , Fernando J Martinez  5
Affiliations
Comment

Reply to Wang and Lai: The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease

MeiLan K Han et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Annual rate of exacerbations in IMPACT by treatment arm stratified by use of ICS at screening. FF/UMEC/VI = fluticasone furoate/umeclidinium/vilanterol; ICS = inhaled corticosteroids; IMPACT = Informing the Pathway of Chronic Obstructive Pulmonary Disease Treatment.
Figure 2.
Figure 2.
Rate ratio comparing fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) and FF/VI with UMEC/VI among IMPACT participants stratified by use of ICS at screening. ICS = inhaled corticosteroids; IMPACT = Informing the Pathway of Chronic Obstructive Pulmonary Disease Treatment.
See this image and copyright information in PMC

Comment on

References

    1. Han MK, Criner GJ, Dransfield MT, Halpin DMG, Jones CE, Kilbride S, et al. The effect of ICS withdrawal and baseline inhaled treatment on exacerbations in the IMPACT study: a randomized, double-blind multicenter trial. Am J Respir Crit Care Med. [online ahead of print] 25 Jun 2020; DOI: 10.1164/rccm.201912-2478OC. - PMC - PubMed

Substances